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A B S T R A C T
The in vitro antimicrobial activity of different fractions obtained from rhizome of Curcuma longa was
investigated against standard strain and clinical isolates of Staphylococcus aureus. The clinical isolates
were found more sensitive for different fractions, than the standard strain of S. aureus. Scanning electron
microscopic observations revealed that test pathogen treated with C. longa extract showed
morphological deformity, with partial lack of the cytoplasmic membrane, which leads to cell disruption
The ability of rhizome of C. longa extracts to inhibit the growth of test pathogen is an indication of its
broad spectrum antimicrobial potential which may be employed in the management of microbial
infections.
ã 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Nosocomial infections are hospital acquired infections. Histori-
cally, staphylococci, pseudomonads, and Escherichia coli have been
the nosocomial infection troika. It is estimated that in United States
in 1995, nosocomial infections cost $4.5 billion and contributed to
more than 88,000 deaths—one death every 6 min [24]. In the study
from 1990 to 1996, the three most common gram-positive
pathogens—Staphylococcus aureus, coagulase-negative staphylo-
cocci, and enterococci— accounted for 34% of nosocomial
infections, and the four most common gram-negative patho-
gens—E. coli, Pseudomonas aeruginosa, Enterobacter spp., and
Klebsiella pneumoniae—accounted for 32% of nosocomial
infections [21].
Major force involved in nosocomial infections is indiscrimi-
nate antimicrobial use in hospitals and long-term care facilities.
Widespread use of cephalosporin antibiotics is often cited as a
cause of the emergence of MRSA, which became a major
nosocomial threat. S. aureus has shown to exhibit resistance to$ This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
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[14,16]. Methicillin–resistant S. aureus (MRSA) is a major
nosocomial pathogen [25]. According to a study, the MRSA
prevalence has increased from 12% in 1992 to 80.83% in 1999 [30].
In addition to this problem, antibiotics are sometimes
associated with adverse effects on the host including hypersensi-
tivity, immune-suppression and allergic reactions [1]. Because of
the side effects and the resistance that pathogenic microorganisms
build against antibiotics, recently much attention has been paid to
extracts and biologically active compounds isolated from plant
species used in herbal medicine [13].
However, the potential of higher plants as sources for new
drugs is still largely unexplored. India is the largest producer of
medicinal herbs and appropriately called the botanical garden of
the world [2]. Coincidentally, the last decade has also witnessed
increasing intensive studies on extracts and biologically active
compounds isolated from plant species used for natural therapies
or herbal medicine [23].
Turmeric (Curcuma longa L.) belongs to the family Zingiber-
aceae, is a perennial rhizomatous shrub native to Southern Asia
[20,31], In India it is popularly known as “Haldi” and is extensively
cultivated in all parts of India [7]. Its rhizomes are oblongonate,
pyriform, often short branched and they are house hold remedy in
Nepal [12]. As a powder called turmeric, it has been in continuous
use for its ﬂavoring, as a spice in both vegetarian and non-
vegetarian food preparations and it also has digestive propertiesC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Phytochemical analysis of various extracts of Curcuma longa (rhizome).
S. no. Secondary metabolites Name of test Various extracts of Curcuma longa
Petroleum ether Benzene Chloroform Methanol Water
1 Alkaloid Mayer’s test    + +
Hager’s test     
2 Tannins and phenolic compounds Ferric chloride test + + + + +
Vanillin hydrochloride test + + + + +
3 Protein Ninhydrin test     
Biuret test     
4 Flavonoids Shinoda test (magnesium hydrochloride reduction test) + + + + +
Alkaline reagent test + + + + +
5 Steroids and triterpenoids Salkowski test     
Libermann–Buchard test     
6 Glycosides Legal test + + + + +
Sodium nitroprusside test + + + + +
7 Carbohydrates Benedit’s test + + + + +
Fehling’s test + + + + +
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activity of the extracts from turmeric (C. longa L.) against common
nosocominal pathogen S. aureus.
2. Material and methods
2.1. Plant material and extraction
The rhizome of C. longa (turmeric) was purchased from market
and 25 gm of dry powder was packed in Soxhlet apparatus for
extraction of respective soluble bioactive molecules from the
rhizome by the use of different solvent (petroleum ether, benzene,
chloroform, methanol and water). Fractions containing volatile
solvents, were concentrated with the help of rotary evaporator
(rota vapor) under reduce pressure. The concentrated extract was
unloaded to sterilized collecting tube.
2.2. Test microorganisms
The standard strains of S. aureus ATCC 6571 used as test
organisms were obtained from All India Institute of Medical
Sciences, New Delhi. While clinical isolates were obtained from
clinical material submitted for diagnostic Microbiology, Depart-
ment of Microbiology, S.N. Medical College, Agra. Cultures of
bacteria were grown on nutrient broth (Hi Media, Mumbai) at 37 C
for 12–14 h and were maintained and preserved on nutrient agar
slants (Hi Media, Mumbai) at 4 C prior to use.
2.3. Phytochemical analysis of the plant extract
Preliminary phytochemical screening of plant was done
following the standard procedures adapted by the variousTable 2
Antimicrobial susceptibility test of different fractions of Curcuma longa rhizome extrac
Test
pathogens
Zone of inhibition (mm)
Petroleum ether Benzene Chloroform 
50 mg/
ml
100 mg/
ml
200 mg/
ml
50 mg/
ml
100 mg/
ml
200 mg/
ml
50 mg/
ml
100 mg
ml
S. aureus
ATCC
6571
19 20 22 17 17 18 9 13 
S. aureus
(CI–I)
15 18 19 9 11 12 10 14 
S. aureus
(CI–II)
15 16 18 10 11 13 12 15 workers [11,17,18]. The extracts were subjected to phytochemical
tests for determination of plant secondary metabolites such as
tannins, saponins, steroid, alkaloids and glycosides in accordance
with [17].
2.4. Antibacterial activity
To check the presence of antimicrobial substance, the
antimicrobial susceptibility tests were performed by standard
disc diffusion method [8]. In this method, antibiogram patterns
were studied for different extracts of C. longa (rhizome) viz
petroleum ether extract, benzene extract, chloroform extract,
methanol extract and aqueous extract for comparing three
concentrations 1250 mg/disc (50 mg/ml), 2500 mg/disc (100 mg/
ml) and 5000 mg/disc (200 mg/ml) based on available literature
[22,9]. Empty sterile discs having a diameter of 6 mm were
impregnated with 25 ml of each serial dilution of extract solution.
These impregnated discs, now contain different concentration
(1250, 2500, 5000 mg/disc) respectively of extract and then
incubated for 15 min for proper diffusion of extract and placed
onto nutrient agar surface spread with 0.1 ml of bacterial culture
(standardized to 0.5 McFarland standards (106 cfu. ml1). The
plates were incubated at 37 C for 12–14 h. The experiments were
carried out in triplicate. The results (mean value n = 3) were
recorded by measuring the zone of growth inhibition around the
discs. Control discs contained DMSO only. For comparison,
standard antibiotic gentamycin inhibiting bacterial cell wall
biosynthesis was included in the assay. The antibacterial spectra
showing zone of inhibition in millimeters and calculated as
percentage by taking gentamycin as positive control with 100%
inhibition.t against S. aureus ATCC 6571 and clinical isolates.
Methanol Aqueous Gentamycin
control
/ 200 mg/
ml
50 mg/
ml
100 mg/
ml
200 mg/
ml
50 mg/
ml
100 mg/
ml
200 mg/
ml
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Fig. 1. Graphical representation of antimicrobial susceptibility test of different fractions of Curcuma longa rhizome extract against S. aureus ATCC 6571 and clinical isolates.
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electron microscopy
For SEM analysis bacterial cell treated with C. longa were
collected by centrifugation of liquid sample at 1120  g for 10 min.
The cell biomass was ﬁxed in the aluminum stubs and coated with
thin layer of gold (ZEISS EVO 40 EP).
3. Results and discussion
3.1. Phytochemical analysis of Curcuma longa extract
Phytochemical analysis of C. longa extract showing antimicro-
bial activity revealed the presence of different active constituents
in different extracts (Table 1). Curcuma longa extract contained
alkaloids, tannin, ﬂavonoid, glycoside and carbohydrate. There are
reports showing that alkaloids and ﬂavonoids are the responsible
compounds for the antibacterial activities in higher plants [10].
3.2. In vitro analysis of Curcuma longa extracts
Antimicrobial susceptibility tests of different fractions of C.
longa rhizome extract against S. aureus ATCC 6571 and clinicalTable 3
Minimum inhibitory concentration of different fractions of Curcuma longa on gram-po
Microorganism Staphylococcus aureus (SR) zone of inhibitio
Name of drug In mm mean As percen
Gentamycin 30 mcg 25 100 
Fraction-I (petroleum ether) 20 73 
1/10 Dilution of fraction-I 18 63 
1/100 Dilution of fraction-I 18 63 
Fraction-II(benzene) 22 84 
1/10 Dilution of fraction-II 20 73 
1/100 Dilution of fraction-II 19 68 
Fraction-III(chloroform) 14 42 
1/10 Dilution of fraction-III 13 36 
1/100 Dilution of fraction-III 12 31 
Fraction-IV(methanol) 25 100 
1/10 Dilution of fraction-IV 23 89 
1/100 Dilution of fraction-IV 22 84 
Fraction-V(aqueous) 20 73 
1/10 Dilution of fraction-V 18 63 
1/100 Dilution of fraction-V 17 57 
Ethylene glycol 6 00 isolates show that all fractions of C. longa rhizome are highly active
against standard and clinical isolates of S. aureus showing zone of
inhibition ranges between 9 mm and 21 mm which was similar to
the study of Negi et al. (1999) who reported the inhibitory effects of
ethanol and hexane extract of turmeric against S. aureus. Further
observations revealed that benzene extract was least active
showing zone of inhibition of about 9 mm at the concentration
of 50 mg/ml while methanolic extract was most active showing
zone of inhibition of about 19 mm at the concentration of 50 mg/
ml. while inhibitory activity of all other fractions ranges between
the two. Similar observations has been reported for species such as
C. longa, Curcuma zedoaria, Curcuma aromatic and Curcuma amada
from the study of [34,35,33,36] (Table 2, Fig. 1).
The minimum inhibitory concentration (MIC) was studied for
different fractions (100 mg/ml i.e., 2500 mg/disc) at 1/10 (250 mg/
disc) and 1/100 (25 mg/disc) dilutions respectively and results are
compared with standard antibiotics as percentage. It was
observed that dilution altered the activity gradually. In case of
S. aureus ATCC 6571 percentage inhibition observed in ﬁrst fraction
of petroleum ether ranges from 73 to 63%, in case of fraction
second of benzene it ranges from 84 to 68%, in case of fraction third
of chloroform it ranges from 42 to 31%, in case of fraction fourth of
methanol it ranges from 100 to 84% and in case of fraction ﬁve ofsitive bacteria with gentamycin as a standard reference.
n Staphylococcus aureus (CI) zone of inhibition
tage In mm mean As percentage
20 100
18 85
17 92
17 92
21 107
19 92
16 71
16 71
15 64
14 57
12 42
10 28
9 21
18 85
17 78
15 64
6 00
Fig. 2. Graphical representation of minimum inhibitory concentration of different fractions of Curcuma longa on gram-positive bacteria with gentamycin as a standard
reference.
54 A. Gupta et al. / Biotechnology Reports 6 (2015) 51–55aqueous it ranges from 73 to 57% and comparing it with clinical
isolate of S. aureus in fraction ﬁrst of petroleum ether ranges from
85 to 92%, in case of fraction second of benzene it ranges from 71 to
107%, in case of fraction third of chloroform it ranges from 57 to
71%, in case of fraction fourth of methanol it ranges from 21 to 42%
and in case of fraction ﬁve of aqueous it ranges from 64 to 85%.
(Table 3, Fig. 2).
Above observations was conﬁrmed by the study of [32] who
evaluated antimicrobial activity of extracts of C. zedoaria and
Curcuma malabarica tubers against six bacterial strains. The MIC
values for different strains and extracts ranged from 0.01 to
0.15 mg/ml in C. zedoaria and from 0.01 to 0.94 mg/ml in C.
malabarica. S. aureus (Gram positive) was inhibited by C. malabarica
but not by C. zedoaria. This study was the ﬁrst report of the
antimicrobial properties of C. malabarica. The ﬁndings also support
the use of C.a zedoaria tubers in traditional medicine for the
treatment of bacterial and fungal infections. While observations of
[26] they evaluated the antibacterial activity of C. longa rhizome
extracts showed that only the clinical isolate of S. aureus showed
more sensitivity towards essential oil fraction than the standard
strain. This was similar to sensitivity pattern of clinical and
standard isolates in our study.
Electron microscopy determined the morphology of the
bacteria after treatment with C. longa extract. The cells that areFig. 3. Untreated Staphylococcus aureus.placed in solution containing 0 ml of C. longa extract for 24 h
showed normal morphology of S. aureus with a multilayered
surface consisting of the outer membrane (Fig. 3). In contrast, the
cells exposed to a 55 ml of (0.5 g/ml) concentration of C. longa
extract for 24 h showed various phases in the process of cell death
(Fig. 4). In Figs. 4 and 5 which correspond to an intermediate from
stage of cell disruption, plasmolysis and partial disappearance of
the cytoplasmic membrane are observed. The structure of the
outer membrane is apparently unaffected at this stage, and the cell
takes on a deformed morphology, with partial lack of the
cytoplasmic membrane. In Fig. 6 which obviously corresponds
to the ﬁnal stage of cell disruption, the outer membrane is
progressively lost and the cytoplasm tends to spill out of the cell
and ﬁnally cell death.
4. Conclusions
Thus, in this study, the efﬁciency of turmeric fractions, such as
petroleum ether, chloroform, benzene, methanol and aqueous
were evaluated for their inhibitory effect on clinical and standard
strains of pathogenic bacteria S. aureus. The methanolic fraction of
C. longa rhizome had high potential to inhibit some pathogenic
bacteria S. aureus to a greater degree than other fractions of
C. longa. In our study the results show that the different fractionsFig. 4. Staphylococcus aureus supplemented with Curcuma longa active compound
indicates partial membrane damage.
Fig. 5. Staphylococcus aureus supplemented with Curcuma longa active compound
indicates the cytoplasm tends to spill out of the bacterial cells.
Fig. 6. Staphylococcus aureus supplemented with Curcuma longa active compound
indicates complete membrane damage.
A. Gupta et al. / Biotechnology Reports 6 (2015) 51–55 55(petroleum ether, methanol etc.) of C. longa rhizome was more
effective antimicrobial agents than the crude extract of C. longa.
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